Procter & Gamble Hygiene and Health Care Limited logo

PGHH

NSE
Procter & Gamble Hygiene and Health Care Limited (SMALL CAP)
Fast Moving Consumer Goods>Fast Moving Consumer Goods>Personal Products>Personal Care
8,993.50
31.00 (0.34%)
Medium VOLATILITY
As on 12 Jun 2026

Price History

Market Cap
₹29.19K Cr
SMALL CAP
P/E Ratio
34.2
Industry
Personal Care
52-Week Range
52W Low8,955+0.4%
52W High14,540-38.1%
Current Price
8,993.50
Circuit Limits (20%)
Lower Circuit7,194.80
Upper Circuit10,792.20
Reference Price
8,993.50

Investment Checklist

Double Top on 1W (BREAKOUT CONFIRMED) — target ₹11460.0
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹12650.0
Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Composite score -42.38 (SELL) with 50.1% confidence
SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))

Technical Analysis

Technical Analysis

Analysis from 2026-06-12

Confidence
50%

Trend

BEARISH
BEARISH

Price below most MAs — downtrend | Bearish MA stack (20<50<200)

EMA20
9411.22
EMA50
9758.12
EMA200
11360.73

Price Action

MIXED
NEUTRAL
Higher Highs3
Higher Lows3
Lower Highs6
Lower Lows5

Support & Resistance Levels

Resistance (Above)
9432.00
9943.00
10387.00
10549.00
11612.00
Support (Below)
8979.00

Volume Analysis

TrendDECREASING
Change-43.10%
Unusual VolumeNo

Stop Loss Levels

Fixed Risk

1% Risk8903.57
3% Risk8723.69
5% Risk8543.82
7% Risk (Custom)
8363.95

Technical Levels

1x ATR (Volatility)8763.78
2x ATR (Swing)8534.06
3x ATR (Trend)8304.34
Immediate Support8979.00

Financials

Financial Analysis

MetricMar '25Jun '25Sep '25Dec '25
Revenue₹989.1 Cr₹935.2 Cr₹1,148.9 Cr₹1,259.9 Cr
Net Profit₹156.1 Cr₹192.1 Cr₹209.9 Cr₹301.5 Cr
EPS₹48.09₹59.17₹64.65₹92.87
Operating Profit₹228.8 Cr₹273.9 Cr₹294.7 Cr₹414.2 Cr
ROE
87.12%
ROCE
124.20%
Debt/Equity
0.00
Current Ratio
1.22
OPM
32.88%
NPM
23.93%

Peer Comparison

Personal Care

Peer Comparison

SymbolNamePriceChange
GODREJCPGodrej Consumer Products Limited₹1,033.30+2.42%
DABURDabur India Limited₹426.40+1.11%
COLPALColgate Palmolive (India) Limited₹2,079.00+2.48%
GILLETTEGillette India Limited₹7,726.00+0.75%
EMAMILTDEmami Limited₹390.80+1.13%
HONASAHonasa Consumer Limited₹413.65-0.96%
BAJAJCONBajaj Consumer Care Limited₹591.65+4.49%
CUPIDCupid Limited₹159.97+3.09%
ANONDITAAnondita Medicare Limited₹1,184.70+4.47%
MACOBSTECHMacobs Technologies Limited₹212.00+0.00%

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All
Ex DatePurposeType
05 Feb 2026
Interim Dividend - Rs 170 Per Share/ Special Dividend - Rs 25 Per Share
SPECIAL_DIVIDEND
28 Aug 2025
Dividend - Rs 65 Per Share
DIVIDEND
20 Feb 2025
Interim Dividend - Rs 110 Per Share
INTERIM_DIVIDEND
19 Nov 2024
Annual General Meeting/Dividend - Rs 95 Per Share
AGM
09 Feb 2024
Interim Dividend - Rs 100 Per Share/ Special Dividend - Rs 60 Per Share
SPECIAL_DIVIDEND

Announcements

Latest updates

View All
DateDescriptionLink
12 Jun 2026
Resignation of Director/KMP/SMP
12 Jun 2026
Change in Management
03 Jun 2026
Analysts/Institutional Investor Meet/Con. Call Updates
28 May 2026
Resignation of Director/KMP/SMP
28 May 2026
Press Release

Board Meetings

Upcoming and past meetings

View All
DatePurposeLinks
28 May 2026
Financial Results/Dividend
28 May 2026
Board Meeting Intimation
30 Jan 2026
Board Meeting Intimation
30 Jan 2026
Financial Results/Dividend
30 Jan 2026
Financial Results

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for PGHH

View All
Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 crore
positive
ET Markets - Industry 4d ago

Carlyle-backed Viyash Scientific buys Italy’s BioForLife for Rs 188 crore

Viyash Scientific, backed by Carlyle, is acquiring Italy's BioForLife for Rs. 188 crore. This move aims to build a leading global companion animal health business. BioForLife offers a strong presence in the Italian pet care market. The acquisition is expected to finalize in the second quarter of FY 2026-27.

AGARWALEYEAMRUTANJANGLOBALGLOBALPETMEDANTAPGHHVIYASHZOTACapital GoodsConsumer Services
NEWS
positive
Business Standard - Markets 5d ago

Viyash Scientific to acquire Milan-based pet care company BioForLife

Viyash Scientific (Viyash), through its wholly owned subsidiary Alivira Animal Health (Alivira), has signed a binding agreement to acquire 100% stake in BioForLife Italia S.r.l. (BFL), a leading pet care company based in Milan, Italy. The acquisition, for a cash consideration of Rs 188 crore is expected to close in Q2 FY27.

AGARWALEYEAMRUTANJANGLOBALPETMEDANTAPGHHVIYASHZOTACapital GoodsFast Moving Consumer Goods
NEWS
positive
Business Standard - Markets 5d ago

Viyash Scientific rises after subsidiary inks Rs 188-crore deal to acquire Italy's BioForLife

Viyash Scientific rose 1.59% to Rs 259.20 after the company's wholly owned subsidiary, Alivira Animal Health, has inked a binding agreement to acquire a 100% stake in BioForLife Italia S.r.l. (BFL), a leading pet care company based in Milan, Italy.

AGARWALEYEAMRUTANJANGLOBALPETMEDANTAPGHHVIYASHZOTACapital GoodsFast Moving Consumer Goods

Frequently Asked Questions